Mucocutaneous leishmaniasis — DTM&H MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Systemic antileishmanial therapy selected using species and regional advice
The best answer is “Systemic antileishmanial therapy selected using species and regional advice”. Mucosal disease can be destructive and is not adequately treated with local therapy. Species, geography, host factors and prior treatment influence the choice between systemic agents such as liposomal amphotericin or antimonials, so specialist tropical-infection management is required.
Reference: WHO: Leishmaniasis fact sheet: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis